Ignite Creation Date:
2025-12-25 @ 12:45 AM
Ignite Modification Date:
2026-05-18 @ 12:08 AM
Study NCT ID:
NCT02409667
Status:
COMPLETED
Last Update Posted:
2019-05-13
First Post:
2015-03-31
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Plaque Psoriasis Efficacy and Safety With Secukinumab
Sponsor:
Novartis Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CAIN457A3302
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None